Regulation of Placental Calcium Transport and Offspring Bone Health by Laura R. Goodfellow et al.
www.frontiersin.org February 2011 | Volume 2 | Article 3 | 1
Review ARticle
published: 14 February 2011
doi: 10.3389/fendo.2011.00003
Regulation of placental calcium transport and offspring bone 
health
Laura R. Goodfellow, Cyrus Cooper and Nicholas C. Harvey*
The MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK
Osteoporosis causes considerable morbidity and mortality in later life, and the risk of the 
disease is strongly determined by peak bone mass, which is achieved in early adulthood. Poor 
intrauterine and early childhood growth are associated with reduced peak bone mass, and 
increased risk of osteoporotic fracture in older age. In this review we describe the regulatory 
aspects of intrauterine bone development, and then summarize the evidence relating early 
growth to later fracture risk. Physiological systems include vitamin D, parathyroid hormone, 
leptin, GH/IGF-1; finally the potential role of epigenetic processes in the underlying mechanisms 
will be explored. Thus factors such as maternal lifestyle, diet, body build, physical activity, and 
vitamin D status in pregnancy all appear to influence offspring bone mineral accrual. These 
data demonstrate a likely interaction between environmental factors and gene expression, a 
phenomenon ubiquitous in the natural world (developmental plasticity), as the potential key 
process. Intervention studies are now required to test the hypotheses generated by these 
epidemiological and physiological findings, to inform potential novel public health interventions 
aimed at improving childhood bone health and reducing the burden of osteoporotic fracture in 
future generations.
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has a huge economic impact, the annual cost to the United States 
has been estimated as $20 billion, and to the European Union as 
$30 billion (Felsenberg et al., 2002).
It appears that an individual’s bone mass (a composite measure 
of bone size and volumetric density) tracks through childhood 
and adolescence to reach a peak in early adulthood (Ferrari et al., 
1998). Therefore, an individual mostly stays in the same position 
in the distribution relative to peers throughout growth, although 
with some potential for temporary deviation from this track as a 
result of changes in nutrition, physical activity, or during puberty. 
Bone mass then declines into older age, with an accelerated rate 
of decline at the female menopause. Osteoporotic fracture risk 
increases continuously as bone mineral density (BMD) declines, 
with a 1.5- to 3-fold increase in the risk for each SD fall in BMD 
(Cummings et al., 1993). The ability to predict fracture risk from 
BMD is at least as good, if not better, than the ability to detect heart 
disease from blood cholesterol levels, and to predict stroke from 
blood pressure values (Marshall et al., 1996).
Preventative strategies against osteoporosis may be aimed at 
either optimizing the peak bone mass obtained, or reducing the 
rate of bone loss. The former approach may be more appropri-
ate for a population based program and modeling studies have 
shown that the magnitude of peak bone mass achieved is a major 
predictors of later osteoporosis risk (Hernandez et al., 2003). 
Peak bone mass is partly inherited, but the currently identified 
genetic markers only explain a small amount of the variation 
in individual peak bone mass and fracture risk (Ralston, 1998; 
Paternoster et al., 2010). Environmental influences during early life 
have been shown to impact upon bone mineral accrual. It is likely 
that this is due to an interaction between environmental factors 
The burden of osTeoporoTic fracTure
Osteoporosis is the commonest bone disorder in Western popu-
lations. It is characterized by low bone mass and microarchitec-
tural deterioration of bone tissue, which lead to increased bone 
fragility and the potentially devastating consequences of fragility 
fracture (Melton and Cooper, 2001). It has been estimated that at 
age 50 the remaining lifetime risk of fracture at the wrist, spine, or 
hip is 39% among women and 13% among men (Sambrook and 
Cooper, 2006). The number of fractures sustained is likely to rise 
substantially over coming years, as fracture rates seem to be rising 
in many parts of the world, and elderly people are the fastest grow-
ing age group worldwide. Even if age-adjusted incidence rates for 
hip fracture increase by only 1% per year, the estimated number 
of hip fractures worldwide will rise from 1.7 million in 1990 to 8.2 
million in 2050 (Sambrook and Cooper, 2006).
Hip fractures are the most devastating consequence of oste-
oporosis: they require hospital admission and are associated with 
an excess mortality of 10–20% in the first year after the fracture 
(Center et al., 1999). Beyond this they are associated with a loss of 
independence, and a subsequent need for residential care. Vertebral 
fractures secondary to osteoporosis can also cause substantial dis-
ability from increased thoracic kyphosis, and long-term back pain. 
Unlike hip fractures only about a third of vertebral fractures result 
from falls; most result from routine activities such as bending or 
lifting (Cooper et al., 1992), therefore interventions aimed at reduc-
ing falls are unlikely to substantially reduce this problem. The third 
type of fracture typically associated with osteoporosis is distal radial 
fracture, although commonly viewed as the mildest outcome of 
osteoporosis, up to 30% of affected individuals may suffer a long-
term complication (O’Neill et al., 2001). Osteoporotic fracture also 
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of calcium ions through a plasma membrane calcium  dependent 
ATPase (Belkacemi et al., 2005). This last group of transport chan-
nels includes four individual plasma membrane Ca2+ ATPase iso-
forms (PMCA 1–4). These have been demonstrated in human 
placenta, as well as in fetal skeletal muscle and brain. PMCA 1 
and 4 are present in most tissues while PMCA 2 and 3 are found 
in more specialized cell types (Stauffer et al., 1993; Zylinska et al., 
2002). In the rat it has been found that a two to threefold increase 
in PMCA gene expression is associated with a 72-fold increase in 
calcium transport across the placenta during late gestation (Glazier 
et al., 1992). The regulation of this process is as yet unknown, 
but at least one of the isoforms of PMCA has been shown to be 
regulated by 1,25(OH)-vitamin D (Kip and Strehler, 2004), and in 
some animals, but not others, 1,25(OH)
2
-vitamin D appears neces-
sary for maintenance of the maternofetal calcium gradient (Lester, 
1986). Work in human subjects has shown that the level of mRNA 
expression of an active placental calcium transporter (PMCA3), 
thought to be situated on the basal membrane of the placenta, is 
positively correlated with whole body bone mineral content (BMC) 
in the offspring at birth (Martin et al., 2005). These observations 
may suggest a possible mechanism for the influence of maternal 
vitamin D status on placental calcium transport and intrauterine 
bone mineral accrual.
influence of The early environmenT on bone 
developmenT
Several lines of evidence suggest that environmental factors act-
ing early in development, for example in utero or early postnatal 
life, may lead to long-term modifications to skeletal development. 
Thus data have accrued from adult cohorts in whom birth records 
existed, mother–offspring cohorts, human physiological studies, 
animal work, and finally investigations into the potential epigenetic 
mechanisms which may underlie these observations.
early growTh and adulT bmc and risk of hip fracTure
The link between the environment in early life and osteoporosis 
risk was first identified in an epidemiological study of 21-year-old 
women born in Bath in 1968 and 1969 (Cooper et al., 1995). A 
statistically significant relationship was found between the girl’s 
weight at 1 year and their adult BMC at the lumbar spine and femo-
ral neck, independent of adult weight and body mass index. Older 
adults (60–75 years) were studied in the Hertfordshire Cohort 
Study, demonstrating a positive relationship between weight at 
1 year and adult BMC (Dennison et al., 2005). The relationships 
remained after adjusting for lifestyle characteristics in adulthood 
including physical activity, dietary calcium intake, cigaret smok-
ing, and alcohol consumption. These findings corroborate observa-
tions from United States, Australia, Sweden, and the Netherlands 
(Cooper et al., 2008).
Hip structure analysis using DXA scan images of the participant 
hips from the Hertfordshire Cohort Study demonstrated a positive 
relationship between weight at 1 year and the inter-trochanteric 
width of the femur, but not femoral neck length at age 60–75 years 
(Javaid et al., 2006b). The association remained after adjustment 
for adult body weight and was independent of proximal femoral 
BMC. This suggests that poor growth in utero and during the first 
year of life is associated with disproportion of the proximal femur in 
and the child’s genome, which establishes a functional level in a 
variety of metabolic  processes involved in skeletal growth. This 
leads to interest in potentially modifiable factors in pregnancy, 
which could have important implications for the bone health of 
future generations.
skeleTal developmenT
For adequate bone development to occur the human fetus requires 
approximately 30 g of calcium during development, which is 
actively transported across the placenta (Widdowson et al., 1988). 
This process starts as early as 20 weeks gestation (Forestier et al., 
1987). To supply the demand for calcium the mother increases both 
calcium absorption from the gut, and bone resorption. Thus there 
may be a decrease in maternal bone mass of around 10% during 
pregnancy (Gambacciani et al., 1995), with potentially further bone 
loss during lactation but recovery of bone mass in the long term 
(Laskey and Prentice, 1999).
A miniature version of the skeleton is laid down in the embry-
onic period, and primary ossification centers form in the verte-
brae and long bones between the 8th and 12th weeks, but it is not 
until the third trimester that the bulk of mineralization occurs 
(Moore and Persaud, 1998).
The main determinant of skeletal mineralization in utero appears 
to be the fetal plasma calcium concentration (Kovacs, 2003), this is 
influenced by the placental transfer (Mughal et al., 1989), and fetal 
management, of calcium (Heaney and Skillman, 1971). Placental 
calcium transfer is thought to be regulated by PTHrP, and injec-
tion of PTHrP into hypothyroidectomized sheep has been shown 
to increase placental calcium flux (Care et al., 1986). Fetal levels 
of PTHrP are increased in response to a low fetal plasma calcium 
levels (Kovacs et al., 1996, 2001b).
Fetal management of calcium is mainly influenced by fetal par-
athyroid hormone (PTH). Lack of parathyroids in fetal mice leads 
to low fetal calcium levels and decreased skeletal mineralization 
(Kovacs et al., 2001a). Fetal PTH seems to act by increasing calcium 
resorption from the kidney, and possibly bone, to increase cal-
cium concentration, but does not affect placental calcium transfer. 
Maternal PTH does not cross the placenta, but affects the fetus by 
altering the concentration of maternal circulating calcium, and 
so the calcium load presented to the fetus, which in turn affects 
levels of fetal PTH. As such maternal hypoparathyroidism can lead 
to fetal parathyroid hyperplasia, and generalized neonatal skeletal 
demineralization (Kovacs, 2003). In addition to its effects on pla-
cental calcium transport PTH and PTHrP directly influence fetal 
bone growth. For example PTHrP has been shown to act on pre-
hypertrophic chondrocytes in the fetal growth plate to inhibit dif-
ferentiation to hypertrophic chondrocytes (Weir et al., 1996; Calvi 
and Schipani, 2000). Both over and under expression of PTHrP or 
its receptor are associated with short-limbed dwarfism in animals 
and humans (Kato et al., 1990; Iwamoto et al., 1994; Karaplis et al., 
1994; Lanske et al., 1996; Vortkamp et al., 1996).
It is unclear how the actions of fetal PTH and PTHrP inter-
act with the characterized molecular apparatus in the placenta: 
Placental calcium transfer occurs in the syncytiotrophoblast and 
proceeds through a sequence of events consisting of facilitated api-
cal entry through a calcium transport channel, cytosolic diffusion 
of calcium bound to calbindin and finally, basolateral extrusion 
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smoking, and socio-economic status. In this study around 31% 
of the mothers had insufficient and 18% had deficient circulat-
ing concentrations of 25(OH)-vitamin D during late pregnancy 
(11–20 and <11 μg/l respectively). Lower concentrations of serum 
25(OH)-vitamin D in mothers during late pregnancy were associ-
ated with reduced whole body BMC and BMD in children at age 
9 years (Javaid et al., 2006a). Estimated exposure to ultraviolet B 
radiation during late pregnancy (p < 0.0001) and the maternal 
use of vitamin D supplements (p = 0.01) both predicted maternal 
25(OH)-vitamin D concentration, and childhood BMC (p = 0.03). 
Adjunctive evidence supporting a role for maternal vitamin D status 
was obtained in the Southampton Women’s Survey, where mater-
nal vitamin D concentrations again correlated with neonatal bone 
mass (Harvey et al., 2008). Findings from the Avon Longitudinal 
Study of Parents and Children (Sayers and Tobias, 2009) further 
reinforced the importance of maternal 25(OH)-vitamin D levels, 
demonstrating a positive association between ambient ultraviolet 
B radiation in pregnancy and offspring BMC at 9 years old.
In developing southern hemisphere populations where sunshine 
is in abundance, often calcium nutrition is a greater issue than that 
of 25(OH)-vitamin D status. Thus in a cohort of mothers and chil-
dren from Pune, India (Ganpule et al., 2006), offspring of women 
who had a higher frequency of intake of calcium-rich foods dur-
ing pregnancy had higher total and lumbar spine BMC and BMD, 
independent of parental size, and bone composition. Circulating 
maternal 25(OH)-vitamin D concentrations in this cohort were 
relatively high, and were not associated with childhood skeletal 
measures. Thus, in populations in nutritional transition, where 
maternal sunlight exposure is sufficient to maintain adequate vita-
min D status, the availability of calcium becomes a more critical 
determinant of fetal and childhood bone mineral accrual.
Moving beyond maternal calcium homeostasis, it is apparent 
that there is a broader relationship between maternal dietary pattern 
and childhood bone mass. Using principal component analysis of 
food frequency questionnaires, a particular pattern of dietary intake 
was observed in the mothers of the Southampton 9 year follow-up 
study. Because this pattern matched closely current guidelines on 
health eating, it was termed the “prudent diet” pattern (Robinson 
et al., 2004; Crozier et al., 2006). Women with high prudent diet 
scores had diets characterized by high intakes of fruit, vegetables, 
wholemeal bread, rice, and pasta, with low intakes of confectionary, 
added sugar, white bread, and crisps. Greater compliance with this 
“healthy” dietary pattern during pregnancy was associated with 
increased offspring whole body and lumbar spine BMD. At age 
9 years (p < 0.001), independent of maternal body build, smoking, 
and physical activity (Cole et al., 2009).
physiological sTudies
Analysis of samples acquired from mother–offspring cohorts has 
allowed the relationships between physiological markers such 
as leptin and IGF-1 and offspring bone mineral accrual to be 
investigated.
lepTin
Leptin is a hormone which is best known for its role in fat metabo-
lism in adults, but laboratory based studies have shown that it has a 
positive effect on mesenchymal cell differentiation into  osteoblasts 
later life leading to a narrower neck but preserved axis length. This 
would correspond to a reduction in the mechanical strength of the 
region, over and above that attributable to BMC alone. Data directly 
linking early growth with adult risk of hip fracture have come from 
the Helsinki Cohort Study (Cooper et al., 2001). Birth and child-
hood growth data from 7000 men and women born in Helsinki 
University Central Hospital during 1924–1933 were linked to hos-
pital discharge records for hip fracture (n = 112). After adjustment 
for age and gender three independent determinants of hip fracture 
risk were identified: tall maternal stature (p < 0.001), shortness at 
birth (p = 0.03), and low rate of childhood growth (height p = 0.006, 
weight p = 0.01). Additionally, people who had hip fractures were 
more likely to be shorter at birth but of average height by age 7 years. 
This suggested that hip fracture risk may be particularly elevated 
among children in whom the growth of the skeletal envelope had 
been forced ahead of its capacity to mineralize.
maTernal lifesTyle, body build, and physical acTiviTy: 
evidence from moTher–offspring cohorTs
There are now data from several mother–offspring cohorts dem-
onstrating relationships between maternal factors in pregnancy 
and offspring bone mass. One of the first studies have examined 
the relationships between maternal body build, nutrition, lifestyle, 
and physical activity during pregnancy and offspring bone size and 
density at birth assessed by DXA. Maternal triceps skinfold thick-
ness at 28 weeks positively correlated with neonatal whole body 
BMC, and mothers who smoked in pregnancy had, on average, 
babies with an 11% lower whole body BMC than mothers who 
did not smoke (Godfrey et al., 2001). Interestingly smoking at the 
time of the last menstrual period was not associated with neonatal 
BMC or areal bone mineral density (BMD = bone mineral content 
divided by bone area), suggesting a fundamental importance of 
the immediate intrauterine environment. High levels of mater-
nal vigorous physical activity in late gestation also predicted that 
reduced BMC at birth.
The Southampton Women’s Survey provided the opportunity to 
further investigate these interactions in a larger sample of 841 infants 
(Harvey et al., 2010). This confirmed that independent predictors of 
greater neonatal whole body bone area and BMC included greater 
maternal birthweight, height, parity, fat stores (triceps skinfold 
thickness), and lower physical activity in late pregnancy. Maternal 
smoking was again statistically significantly (and independently) 
associated with lower neonatal bone mass. Additionally great parity 
and maternal fat stores, and lower physical activity predicted greater 
bone width in the offspring. These relationships were observed in 
both male and female neonates.
viTamin d and calcium nuTriTion
The mother–offspring cohorts also provide a platform to investigate 
the mechanism of interactions between intrauterine environment 
and later bone health. Calcium and vitamin D, being key nutrients 
in bone development, are prime candidates for investigation. In a 
study of 9-year-old children born to mothers involved in a nutrition 
in pregnancy study in Southampton, whole body BMC, and BMD 
in childhood were positively associated with ionized calcium level 
in the umbilical cord of the child at birth (Javaid et al., 2006a). This 
association appeared to mediate the effects of maternal fat stores, 
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In this way the vole offspring is able to adapt for the season into 
which it will be born. Clearly such an adaptation could not arise 
through fixed genetic change. Evidence for a prolonged effect of an 
adverse intrauterine environment on genetically identical individu-
als come from studies of monozygotic twins. Thus in a UK study 
of 445 monozygotic (MZ) and 966 dizygotic (DZ) healthy female 
twins, at a mean age of 47 years, birth weight was found to positively 
predict BMC and BMD (Antoniades et al., 2003). The MZ twins, 
despite being genetically identical, had greater intra-pair variability 
in birth weight than DZ twins. This highlights the crucial role of the 
placenta in development, as two-thirds of the MZ twins will have 
shared a placenta, whereas the DZ twins will have had a placenta 
each. A majority of the MZ twins therefore had to compete for 
placental resources, with a subsequent compromise in their growth 
potential. Furthermore, in the MZ twins compared to the DZ twins 
there was a stronger intra-pair association between birth weight 
and bone density. This suggests that the early adverse environment 
of the smaller MZ twin, when competing for placental resources, 
strongly influenced their future adult skeletal status.
In humans the influence of the intrauterine environment was 
initially demonstrated by the observation that the risk of hyper-
tension, coronary heart disease, and diabetes is increased in those 
individuals born with low birthweight (Godfrey et al., 1997; Barker, 
1998; Gluckman and Hanson, 2004). The data presented above 
demonstrate that similar associations are observed for osteoporosis. 
The key mechanistic point is that it is likely to be not just genes or 
environment that is important, but an interaction between the two. 
Thus in the Hertfordshire Cohort Study there was no significant 
association between either vitamin D receptor (VDR) genotype 
and adult BMD in the cohort as a whole (Dennison et al., 2001). 
However the relationship between lumbar spine BMD and VDR 
varied according to birth weight. After adjusting for age, gender, 
and adult weight individuals in the lowest third for birthweight had 
a higher spine BMD if they were of the BB genotype (p = 0.01). 
People of the same genotype who were in the highest third for 
birth weight had a lower spine BMD compared to those of bb 
genotype in the same birth weight category (p = 0.04). Similar 
interactions between birthweight and genome were observed for 
the GH gene (Dennison et al., 2004). What is needed therefore, is a 
scientific mechanism that can explain the interaction between the 
environment and genome, and this is provided by considering the 
epigenetic modification of gene expression.
epigeneTics
Epigenetics refers to heritable information that is not contained 
in the underlying DNA sequence (Jaenisch and Bird, 2003). Each 
cell in the body is said to acquire a unique “epigenetic signature” 
reflecting the genotype, developmental history, and environmental 
influences upon the cell (Morgan et al., 2005). These changes then 
influence cell function, and so the phenotype of the organism. The 
two most studied forms of epigenetic marking are DNA methyla-
tion and histone modification. DNA methylation involves the addi-
tion of a methyl group to cytosine residues at the carbon-5 position 
of CpG dinucleotides. DNA methylation is generally associated with 
gene repression, either by decreased binding of transcription factors 
or by attracting methyl-CpG-binding proteins that act as tran-
scriptional repressors (Gluckman et al., 2007; Gicquel et al., 2008). 
(Thomas et al., 1999; Kiyokawa et al., 2001). Leptin receptors have 
been found on osteoblasts, chondrocytes, and bone marrow stro-
mal cells. Leptin is produced in the feto-placental circulation by 
fetal fat, heart, liver, muscle, and interestingly the placenta itself 
(Masuzaki et al., 1997; Lepercq et al., 2001). Using umbilical cord 
samples from 93 neonates Javaid et al. (2005) were able to show that 
serum leptin at birth was related strongly to neonatal whole body 
BMC, bone area, and estimated volumetric BMD. In a more recent 
study, growth velocity of fetal abdominal circumference, which is 
a composite measure of adiposity and liver volume, positively pre-
dicted estimated volumetric bone density at 4 years (Harvey et al., 
2009). Thus fetal leptin may be an important regulator of bone 
development. The human placenta is likely to be instrumental in 
this regulation, both through its role as a barrier between maternal 
and fetal leptin, and through fetal leptin production. The detailed 
regulation of fetal leptin has yet to be elucidated, as has the relation-
ship between leptin, adiposity, and fetal bone mass.
growTh hormone and igf-1
Developing chondrocytes have been found to express insulin like 
growth factor-1 (IGF-1) mRNA, and it has been shown to stimu-
late their proliferation (Olney and Mougey, 1999). The placenta 
acts as a barrier between the maternal and fetal IGF systems, with 
fetal IGF predominantly produced in the fetal liver. Using the same 
subjects as the leptin study Javaid et al. (2004) found that umbilical 
cord serum IGF-1 concentration positively correlated with neonatal 
whole body BMC, lean mass, and fat mass. Cord serum IGF-1 levels 
partly explained the effect of maternal smoking upon offspring 
skeletal development, but did not account for the other previously 
demonstrated parental characteristics, such as height, weight, and 
fat mass. This suggested that both IGF-1 dependent and independ-
ent factors influence bone parameters of the neonate.
In adults profiles of circulating growth hormone (GH) and cor-
tisol were compared to bone density and birth records of patients 
in the Hertfordshire cohort study (Fall et al., 1998; Phillips et al., 
1998; Dennison et al., 1999). It was found that weight at 1 year 
positively correlated with median GH concentration and negatively 
correlated with cortisol concentration at age 61–72 years, suggesting 
a “memory” of a difficult intrauterine, or early life environment. 
Furthermore the profiles of these two hormones were found to be 
determinants of prospectively determined bone loss rate, suggest-
ing a physiological outcome of this “memory.” This suggests that, 
unlike leptin, the GH–IGF axis is instrumental in both the forma-
tion and maintenance of skeletal health, additionally the ability of 
this system to maintain skeletal health may be influenced by the 
events of intrauterine life.
developmenTal plasTiciTy and gene–environmenT 
inTeracTions
There is a strong biological basis for a model of disease pathogen-
esis in which a single genotype can give rise to several different 
phenotypes, allowing the organism to adapt future generations to 
prevailing environmental conditions: this phenomenon is termed 
developmental plasticity (Bateson et al., 2004). There are striking 
illustrations of such phenomena in the natural world: for example 
the thickness of the meadow vole’s coat is determined exclusively by 
the amount of light the mother is exposed to prenatally (Lee, 1993). 
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this could be an increased sensitivity of osteoblasts to cortisol, 
which may act to decrease bone mineral density. This would be 
consistent with the findings of a positive association between birth 
weight and basal levels of cortisol (Phillips et al., 1998), and the 
negative association between integrated cortisol concentration 
and bone density in adults from the Hertfordshire cohort study 
(Dennison et al., 1999).
The second area of current research into the epigenomic changes 
associated with osteoporosis has directly focused on the placenta. 
It is known that placental calcium transport is dependent upon a 
series of transport proteins in the syncytiotrophoblast, and as dis-
cussed earlier umbilical cord calcium levels correlated with BMC 
when the child was age 9 years (Javaid et al., 2006a). A family of 
plasma membrane ATPase isoforms (PMCA1–4) are thought to be 
a rate limiting step in the placental calcium transportation. Using 
placental tissue samples from 70 placentae it was found that expres-
sion of PMCA3 mRNA predicted neonatal BMC (Martin et al., 
2007). Furthermore this relationship was independent of maternal 
height, pre-pregnancy fat stores, parity, physical activity, smoking, 
and calcium intake. 1,25(OH)-vitamin D has been shown to regu-
late other PMCA isoforms (Kip and Strehler, 2004) and is therefore 
a potential candidate. Figure 1 summarizes the path of calcium 
across the placenta from mother to fetus.
conclusion
Osteoporosis is a major cause of morbidity and mortality through 
its association with age-related fractures. It is becoming increas-
ingly clear that there is a relationship between growth and devel-
opment in early life and bone health in older age. It is likely that 
this is mediated, at least in part, by the main interface between the 
mother and her fetus, the placenta. Epigenetic processes may be 
the mechanism by which the “memory” of early life environment 
in stored in the offspring. Future understanding of the nature, tim-
ing and transduction of epigenetic changes could point toward 
potential biomarkers for later life diseases, and suggest focused 
interventions. It is envisaged that the placenta will play a central role 
in this research, which ultimately aims to develop novel strategies 
to improve skeletal health throughout the life course, and reduce 
osteoporotic fracture in future generations.
Histone modification refers to post-translational  modification of 
histone tails. Histones are involved in the packaging of DNA into 
chromatin, and if the way that DNA is wrapped around the histones 
changes, gene expression can also change.
With the formation of a new organism most, but not all, of the 
epigenetic markings of the previous generation are wiped out. This 
occurs during two major points in development: gametogenesis and 
preimplantation development (Morgan et al., 2005). During game-
togenesis the primordial germ cells undergo demethylation in the 
embryo, including at imprinted genes. The genomes of the gametes 
then acquire imprints and undergo de novo methylation in differ-
ing ways according to the sex of the embryo. In males this process 
finishes during embryological development, whilst in females this 
continues until adult life in maturing oocytes. When these gam-
etes are fertilized, but before implantation, the new embryo then 
undergoes a second round of demethylation, however this time 
imprinted genes are not demethylated. As the new embryo implants 
new methylation patterns become established via de novo methyla-
tion by the activities of DNA methyltransferases.
From this baseline level of methylation epigenetic mechanisms 
are then thought to influence a range of processes, including the 
commitment of cells to develop a particular lineage (Morgan et al., 
2005), and adaptations the organism makes in response to its envi-
ronment (Bird, 2007). Thus it has been found that humans exposed 
to the Dutch hunger winter of 1944–1945 at the time of conception 
had less DNA methylation of the imprinted IGF-2 gene (a key factor 
in growth and development) 60 years later, compared to their same 
sex siblings (Heijmans et al., 2008). More recent analysis of the chil-
dren born during the Dutch hunger winter has now identified genes 
which show epigenetic changes associated with famine exposure 
later in pregnancy (Tobi et al., 2009). The early life environment 
has been shown to have an influence upon epigenetic marking of 
the glucocorticoid receptor in rats (Weaver et al., 2004). Rat pups 
nursed by mothers with a particular style of nursing behavior, with 
more licking and grooming, have been found to be less fearful and 
better able to cope with stress. Rat pups nursed by the attentive 
mothers were shown to have an altered pattern of methylation of 
their glucocorticoid receptors; these differences emerged in the 
first week of life, were reversed by cross fostering, and persisted 
into adulthood (Weaver et al., 2004).
In rats protein restriction during pregnancy is associated with 
reduced expression of a particular DNA methyl transferase (Dnmt1; 
Lillycrop et al., 2007) in the liver of the adult offspring. Dnmt1 
is involved in maintaining patterns of DNA methylation through 
mitosis (Bird, 2002). Dnmt1 methylation has been demonstrated 
in human umbilical cord, and in both the human umbilical cord 
and the rat liver Dnmt1 expression was associated with the degree 
of methylation of the glucocorticoid receptor promoter. Indeed, 
in human umbilical cord Dnmt1 expression predicted 49% of the 
variation in methylation of the glucocorticoid receptor promoter 
(Lillycrop et al., 2007). As would be expected methylation of the 
glucocorticoid receptor promoter was associated with reduced 
expression of the receptor protein (Lillycrop et al., 2007). It is 
therefore suggested that maternal dietary restriction in pregnancy 
may result in reduced fetal Dnmt1 expression, leading to reduced 
methylation of the glucocorticoid receptor promoter, causing 
increased expression of the glucocorticoid receptor. An effect of 
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FigurE 1 | Placental calcium transport: Calcium enters from the 
maternal circulation via facilitated transporters (CAT 1 and 2), crosses the 
cytosol bound to proteins such as calbindin and is then actively extruded 
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